Jones Trading Reiterates Buy Rating on Rezolute (RZLT) following FDA lift of clinical hold on RZ358

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/14/2026

1. GLOB
2. AMAT
3. RDDT
4. DGNX
5. SPY
6. ELUT
7. CV
8. BRUN
9. ADYEN:NA
10. ADYYF

Go back to Jones Trading Reiterates Buy Rating on Rezolute (RZLT) following FDA lift of clinical hold on RZ358

Rezolute (RZLT) PT Raised to $15 at BTIG

September 9, 2024 11:58 AM EDT

BTIG analyst Julian Harrison raised the price target on Rezolute (NASDAQ: RZLT) to $15.00 (from $13.00) while maintaining a Buy rating.

The analyst comments "The FDA has lifted the partial clinical holds (minimum age restriction of 12 years and drug exposure limit of ~3mg/kg per... More